Researchers assessed popular social media platforms to determine the prevalence of misinformation related to prostate cancer.

WASHINGTON — President Trump said Sunday that he planned to help the creator of the satirical comic strip “Dilbert” get access to a prostate cancer drug.

A cancer clinical trial of ivermectin is included in plans for a state-funded medical research program in Florida. (Washington Post) A new startup focuses on developing oral cancer drugs that release ...

The way ivermectin works to kill cancer cells is extremely complicated. It can cause apoptosis which is a self-induced death of cancer cells. It's thought to slow or hinder tumor cell growth and in ...

Health Canada is warning consumers about multiple unauthorized drug products seized from Ezra Healing located at 100-2041 Harvey Ave, in Kelowna, British Columbia. The products are labelled to contain ...

Movember is back. Throughout the month of November, men are skipping their razors in favour of sporting a moustache to help ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific ...

New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of ...

New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of ...

The Dilbert creator, who is battling prostate cancer, is a prominent—sometimes controversial—supporter of the President.

Prostate cancer is something that nobody wants to have. Thankfully, with modern medical advancements, there are different ...